Sarissa Capital Management LP

Sarissa Capital Management LP, a DE Limited Partnership with 9 employees, 6 of which are in advisory roles, has an unknown number of clients. Their SEC status is Approved, with a registration date of April 10, 2013.

• ALEXANDER JOHN DENNER

  CHIEF EXECUTIVE OFFICER/CHIEF INVESTMENT OFFICER owns 75% or more

• MARK ANTHONY DIPAOLO

  CHIEF LEGAL OFFICER/GENERAL COUNSEL owns less than 5%

• PATRICE EADON BONFIGLIO

  CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER owns less than 5%

• SARISSA CAPITAL MANAGEMENT GP LLC

  GENERAL PARTNER owns less than 5%

• ALEXANDER JOHN DENNER

  MANAGING MEMBER owns 75% or more

• DEUTSCHE BANK SECURITIES INC.
  United States
• J.P. MORGAN CLEARING CORP.
  United States
• MORGAN STANLEY & CO. LLC
  United States
• MORGAN STANLEY PRIVATE BANK NATIONAL ASSOCIATION
  United States

• IVY Equities II LLC
• Algonquin Advisors LLC
• COOK Pine Capital LLC
• GSCP NJ LP
• Oxford Bridge Management LLC
• Cross Ocean Partners Management LP
• Arrowhead Investment Management LLC
• Southpaw Asset Management LP
• Renaissance Capital LLC
• Good Hill Partners LP

• Sarissa Capital Management LP Q3 2022 vs. Q4 2022 13F Holdings Comparison: Winners and Losers in the Pharma and Biotech Sectors

• ALLERGAN PLC $174,545k
• MEDICINES CO $153,246k
• BIOGEN INC $150,378k
• IRONWOOD PHARMACEUCL $106,314k
• Innoviva Inc $90,883k
• INTERCEPT PHARMACEUTICALS $60,234k
• JAZZ PHARMA PLC $28,013k
• PUMA BIOTECHNOLOGY INC $18,010k
• MERSANA THERAPEUTICS INC $15,187k
• CYCLERION THERAPEUTI $2,862k